JANSSEN R&D IRELAND — TTAB Proceedings
JANSSEN R&D IRELAND is a party to 7 TTAB proceedings.
Proceedings
- Proceeding 91215567 — Oppositions, Terminated (filed 2014-03-24) against GlaxoSmithKline Intellectual Property Limited as defendant
- Proceeding 91213665 — Oppositions, Terminated (filed 2013-11-25) against Teva Pharmaceutical Industries Limited as plaintiff
- Proceeding 85845780 — Extensions of Time to Oppose, Terminated (filed 2013-10-16) against GlaxoSmithKline Intellectual Property Limited as defendant
- Proceeding 85857195 — Extensions of Time to Oppose, Terminated (filed 2013-09-18) against Teva Pharmaceuticals Europe B.V. as plaintiff
- Proceeding 91208377 — Oppositions, Terminated (filed 2013-05-16) against Merck KGAA as defendant
- Proceeding 85283635 — Extensions of Time to Oppose, Terminated (filed 2012-09-25) against MERCK KGAA as defendant
- Proceeding 85283635 — Ex Parte Appeal, Terminated (filed 2012-07-30) as plaintiff
Marks in These TTAB Matters
Common TTAB Counterparties
- GlaxoSmithKline Intellectual Property Limited — 2 proceedings
- MERCK KGAA — 2 proceedings
- Teva Pharmaceutical Industries Limited — 1 proceedings
- Teva Pharmaceuticals Europe B.V. — 1 proceedings
Recent TTAB Timeline
- 2014-07-14: 91215567 — TERMINATED involving GlaxoSmithKline Intellectual Property Limited
- 2014-07-14: 91215567 — BD'S DECISION: DISMISSED W/O PREJUDICE involving GlaxoSmithKline Intellectual Property Limited
- 2014-06-30: 91215567 — WITHDRAWAL OF OPPOSITION involving GlaxoSmithKline Intellectual Property Limited
- 2014-06-16: 91215567 — MOT TO AMEND APPLICATION involving GlaxoSmithKline Intellectual Property Limited
- 2014-05-31: 91215567 — EXTENSION OF TIME GRANTED involving GlaxoSmithKline Intellectual Property Limited
- 2014-05-31: 91215567 — STIPULATION FOR AN EXTENSION OF TIME involving GlaxoSmithKline Intellectual Property Limited
- 2014-05-05: 91215567 — EXTENSION OF TIME GRANTED involving GlaxoSmithKline Intellectual Property Limited
- 2014-05-05: 91215567 — STIPULATION FOR AN EXTENSION OF TIME involving GlaxoSmithKline Intellectual Property Limited
- 2014-04-03: 91213665 — TERMINATED involving Teva Pharmaceutical Industries Limited
- 2014-04-03: 91213665 — BD'S DECISION: DISMISSED W/O PREJUDICE involving Teva Pharmaceutical Industries Limited
- 2014-04-03: 91213665 — WITHDRAWAL OF APPLICATION involving Teva Pharmaceutical Industries Limited
- 2014-03-24: 91215567 — PENDING, INSTITUTED involving GlaxoSmithKline Intellectual Property Limited
- 2014-03-24: 91215567 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving GlaxoSmithKline Intellectual Property Limited
- 2014-03-24: 91215567 — FILED AND FEE involving GlaxoSmithKline Intellectual Property Limited
- 2014-02-03: 91213665 — ANSWER involving Teva Pharmaceutical Industries Limited
- 2014-01-20: 85845780 — EXTENSION OF TIME GRANTED involving GlaxoSmithKline Intellectual Property Limited
- 2014-01-20: 85845780 — INCOMING - EXT TIME TO OPPOSE FILED involving GlaxoSmithKline Intellectual Property Limited
- 2013-12-20: 91213665 — EXTENSION OF TIME GRANTED involving Teva Pharmaceutical Industries Limited
- 2013-12-20: 91213665 — D'S MOT FOR EXTEN. OF TIME W/ CONSENT involving Teva Pharmaceutical Industries Limited
- 2013-12-20: 91213665 — CHANGE OF CORRESPONDENCE ADDRESS involving Teva Pharmaceutical Industries Limited
- 2013-11-25: 91213665 — PENDING, INSTITUTED involving Teva Pharmaceutical Industries Limited
- 2013-11-25: 91213665 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving Teva Pharmaceutical Industries Limited
- 2013-11-25: 91213665 — FILED AND FEE involving Teva Pharmaceutical Industries Limited
- 2013-10-17: 91208377 — TERMINATED involving Merck KGAA
- 2013-10-17: 91208377 — BD'S DECISION: DISMISSED W/ PREJUDICE involving Merck KGAA
- 2013-10-16: 85845780 — EXTENSION OF TIME GRANTED involving GlaxoSmithKline Intellectual Property Limited
- 2013-10-16: 85845780 — INCOMING - EXT TIME TO OPPOSE FILED involving GlaxoSmithKline Intellectual Property Limited
- 2013-10-10: 91208377 — WITHDRAWAL OF OPPOSITION involving Merck KGAA
- 2013-09-23: 91208377 — SUSPENDED involving Merck KGAA
- 2013-09-23: 91208377 — D MOT TO SUSP W/ CONSENT PEND SETTL NEGOTIATIONS involving Merck KGAA